ADUC Trademark

Trademark Overview

On Tuesday, May 20, 2025, a trademark application was filed for ADUC with the United States Patent and Trademark Office. The USPTO has given the ADUC trademark a serial number of 79429112. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, July 31, 2025. This trademark is owned by KOWA COMPANY, LTD.. The ADUC trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment and prevention of cardiovascular disease, cerebrovascular disease, dyslipidemia, thrombosis, hyperphosphatemia, hypertension, diabetes, cancer, oncological disease, leukemia, metastasis, immunological disorder, autoimmune disease, bacterial infection, viral infection, pain, central nervous system disease, neurological disease, mood disorders, musculoskeletal disorders, kidney disease, skin disease, osteoporosis, ophthalmic disorders, sensory organ disorders, aging-related diseases; veterinary preparations for the treatment and prevention of cardiovascular disease, cerebrovascular disease, dyslipidemia, thrombosis, hyperphosphatemia, hypertension, diabetes, cancer, oncological disease, leukemia, metastasis, immunological disorder, autoimmune disease, bacterial infection, viral infection, pain, central nervous system disease, neurological disease, mood disorders, musculoskeletal disorders, kidney disease, skin disease, osteoporo...
aduc

General Information

Serial Number79429112
Word MarkADUC
Filing DateTuesday, May 20, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateThursday, July 31, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the treatment and prevention of cardiovascular disease, cerebrovascular disease, dyslipidemia, thrombosis, hyperphosphatemia, hypertension, diabetes, cancer, oncological disease, leukemia, metastasis, immunological disorder, autoimmune disease, bacterial infection, viral infection, pain, central nervous system disease, neurological disease, mood disorders, musculoskeletal disorders, kidney disease, skin disease, osteoporosis, ophthalmic disorders, sensory organ disorders, aging-related diseases; veterinary preparations for the treatment and prevention of cardiovascular disease, cerebrovascular disease, dyslipidemia, thrombosis, hyperphosphatemia, hypertension, diabetes, cancer, oncological disease, leukemia, metastasis, immunological disorder, autoimmune disease, bacterial infection, viral infection, pain, central nervous system disease, neurological disease, mood disorders, musculoskeletal disorders, kidney disease, skin disease, osteoporosis, ophthalmic disorders, sensory organ disorders, aging-related diseases; vaccines for the treatment and prevention of cardiovascular disease, cerebrovascular disease, dyslipidemia, thrombosis, hyperphosphatemia, hypertension, diabetes, cancer, oncological disease, leukemia, metastasis, immunological disorder, autoimmune disease, bacterial infection, viral infection, pain, central nervous system disease, neurological disease, mood disorders, musculoskeletal disorders, kidney disease, skin disease, osteoporosis, ophthalmic disorders, sensory organ disorders, aging-related diseases; therapeutic medicines for the treatment and prevention of cardiovascular disease, cerebrovascular disease, dyslipidemia, thrombosis, hyperphosphatemia, hypertension, diabetes, cancer, oncological disease, leukemia, metastasis, immunological disorder, autoimmune disease, bacterial infection, viral infection, pain, central nervous system disease, neurological disease, mood disorders, musculoskeletal disorders, kidney disease, skin disease, osteoporosis, ophthalmic disorders, sensory organ disorders, aging-related diseases; therapeutic antibodies for the treatment and prevention of cardiovascular disease, cerebrovascular disease, dyslipidemia, thrombosis, hyperphosphatemia, hypertension, diabetes, cancer, oncological disease, leukemia, metastasis, immunological disorder, autoimmune disease, bacterial infection, viral infection, pain, central nervous system disease, neurological disease, mood disorders, musculoskeletal disorders, kidney disease, skin disease, osteoporosis, ophthalmic disorders, sensory organ disorders, aging-related diseases.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 12, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameKOWA COMPANY, LTD.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events

Event DateEvent Description
Monday, August 11, 2025LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, August 14, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 14, 2025APPLICATION FILING RECEIPT MAILED
Thursday, July 31, 2025SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

aduc disease disorders infection pain central disorder viral nervous autoimmune neurological